SITEONE THERAPEUTICS

SiteOne Therapeutics is a San Francisco-based company that develops novel therapeutics and diagnostics. They develop products safely, effectively, and efficiently treat acute and chronic pain without the limitations of existing therapies, such as NSAIDs and opioids. Their lead therapeutic candidates are highly selective inhibitors of a voltage-gated sodium ion channel, Naᵥ1.7, which plays a critical role in the generation and conduction of pain signals.

#People #Financial #Website #More

SITEONE THERAPEUTICS

Industry:

Biotechnology Health Diagnostics Medical Therapeutics

Founded:

2010-01-01

Address:

Bozeman, Montana, United States

Country:

United States

Website Url:

http://www.siteonetherapeutics.com

Total Employee:

1+

Status:

Active

Contact:

+1 (406) 602-4558

Email Addresses:

[email protected]

Total Funding:

19.18 M USD

Technology used in webpage:

Google Font API Google Apps For Business Google Maps AJAX Libraries API GoDaddy DNS GStatic Google Static Content Google Maps API Squarespace Hosted

Current Advisors List

will-price_image

Will Price Board Member @ SiteOne Therapeutics
Board_member

justin-du-bois_image

Justin Du Bois Board Member @ SiteOne Therapeutics
Board_member

lowell-sears_image

Lowell Sears Chairman of the Board and Lead Investor @ SiteOne Therapeutics
Board_member
2014-09-01

not_available_image

Rick Orr Board Member @ SiteOne Therapeutics
Board_member

stan-abel_image

Stan Abel Board Member @ SiteOne Therapeutics
Board_member

joe-zakrzewski_image

Joe Zakrzewski Board Member @ SiteOne Therapeutics
Board_member

scott-braunstein_image

Scott Braunstein Board Member @ SiteOne Therapeutics
Board_member
2018-01-01

joseph-zakrzewski_image

Joseph Zakrzewski Board Member @ SiteOne Therapeutics
Board_member
2014-07-01

Current Employees Featured

george-miljanich_image

George Miljanich
George Miljanich Co-Founder & Chief Scientific Officer @ SiteOne Therapeutics
Co-Founder & Chief Scientific Officer

john-mulcahy_image

John Mulcahy
John Mulcahy Vice President, Research @ SiteOne Therapeutics
Vice President, Research
2010-03-01

stan-abel_image

Stan Abel
Stan Abel Chairman Of The Board Of Directors @ SiteOne Therapeutics
Chairman Of The Board Of Directors
2020-12-01

david-c-yeomans_image

David C Yeomans
David C Yeomans Founder @ SiteOne Therapeutics
Founder
2010-08-01

stan-abel_image

Stan Abel
Stan Abel CEO @ SiteOne Therapeutics
CEO

Founder

david-c-yeomans_image

David C Yeomans

george-miljanich_image

George Miljanich

john-mulcahy_image

John Mulcahy

Investors List

amgen-2_image

Amgen

Amgen investment in Series B - SiteOne Therapeutics

mission-bay-capital-llc_image

Mission Bay Capital

Mission Bay Capital investment in Series B - SiteOne Therapeutics

next-frontier-capital_image

NEXT Frontier Capital

NEXT Frontier Capital investment in Series B - SiteOne Therapeutics

z-investments_image

Z Investments

Z Investments investment in Series B - SiteOne Therapeutics

biobrit-llc_image

BioBrit

BioBrit investment in Series B - SiteOne Therapeutics

bioinnovation-capital_image

Mission BioCapital

Mission BioCapital investment in Series B - SiteOne Therapeutics

2m-companies_image

2M Companies

2M Companies investment in Series B - SiteOne Therapeutics

sears-capital-management_image

Sears Capital Management

Sears Capital Management investment in Series B - SiteOne Therapeutics

mission-bay-capital-llc_image

Mission Bay Capital

Mission Bay Capital investment in Venture Round - SiteOne Therapeutics

sears-capital-management_image

Sears Capital Management

Sears Capital Management investment in Venture Round - SiteOne Therapeutics

Official Site Inspections

http://www.siteonetherapeutics.com

Host Informations
Whois Informations

Loading ...

More informations about "SiteOne Therapeutics" on Search Engine